Saudi Arabia Oligonucleotide Synthesis Market Size & Outlook
Related Markets
Saudi Arabia oligonucleotide synthesis market highlights
- The Saudi Arabia oligonucleotide synthesis market generated a revenue of USD 20.1 million in 2025 and is expected to reach USD 56.1 million by 2033.
- The Saudi Arabia market is expected to grow at a CAGR of 14.1% from 2026 to 2033.
- In terms of segment, services was the largest revenue generating product in 2025.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
Oligonucleotide synthesis market data book summary
| Market revenue in 2025 | USD 20.1 million |
| Market revenue in 2033 | USD 56.1 million |
| Growth rate | 14.1% (CAGR from 2026 to 2033) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oligonucleotides, Equipment/Synthesizer, Reagents, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc Common Stock, Agilent Technologies, Kaneka Corp, Heritage Global Inc, Twist Bioscience Corp, Bio-Synthesis, Biolegio |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.6% of the global oligonucleotide synthesis market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Middle East & Africa, Saudi Arabia oligonucleotide synthesis market is projected to lead the regional market in terms of revenue in 2033.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 56.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oligonucleotide Synthesis Market Scope
Oligonucleotide Synthesis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Biolegio | View profile | 11-50 | Nijmegen, Gelderland, The Netherlands, Europe | http://www.biolegio.com |
| Bio-Synthesis | View profile | 11-50 | Seminole, Texas, United States, North America | http://www.biosyn.com |
| Twist Bioscience Corp | View profile | 919 | 681 Gateway Boulevard, South San Francisco, CA, United States, 94080 | https://www.twistbioscience.com |
| Heritage Global Inc | View profile | 82 | 12625 High Bluff Drive, Suite 305, San Diego, CA, United States, 92130 | https://www.hginc.com |
| Kaneka Corp | View profile | 13284 | 3-2-4, Nakanoshima, Kita-ku, Osaka, Japan, 530-8288 | http://www.kaneka.co.jp |
| Agilent Technologies | View profile | 10001+ | Santa Clara, California, United States, North America | http://www.agilent.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Saudi Arabia oligonucleotide synthesis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oligonucleotide synthesis market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 42.29% in 2025. Horizon Databook has segmented the Saudi Arabia oligonucleotide synthesis market based on oligonucleotides, equipment/synthesizer, reagents, services covering the revenue growth of each sub-segment from 2021 to 2033.
Saudi Arabia has been investing in biotechnology and life sciences initiatives, including R&D. The growth of these initiatives is expected to drive the demand for oligonucleotide synthesis in various applications, such as genomics, diagnostics, and therapeutics.
The government initiated Saudi Human Genome Program in 2018 to develop the field of diagnostics and prevent genetic diseases. In addition, extensive research studies involving sequencing can help expand the usage rate of advanced DNA sequencing techniques in this country.
According to the Centre for Arab Genomic Studies, Saudi Arabia has a high burden of genetic diseases, primarily due to consanguinity. The number of cancer cases and deaths has also increased in recent years in the country. As per the GLOBOCAN data, in 2020, around 27,885 new cancer cases were diagnosed in Saudi Arabia and around 13,069 people succumbed to cancer.
Reasons to subscribe to Saudi Arabia oligonucleotide synthesis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia oligonucleotide synthesis market databook
-
Our clientele includes a mix of oligonucleotide synthesis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia oligonucleotide synthesis market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia oligonucleotide synthesis market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia oligonucleotide synthesis market size, by product, 2021-2033 (US$M)
Saudi Arabia Oligonucleotide Synthesis Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
